Senior Director, Cell Therapy, Medical Evidence Generation (MEG) Lead
Company: Disability Solutions
Location: Princeton
Posted on: May 3, 2024
Job Description:
Working with UsChallenging. Meaningful. Life-changing. Those
aren't words that are usually associated with a job. But working at
Bristol Myers Squibb is anything but usual. Here, uniquely
interesting work happens every day, in every department. From
optimizing a production line to the latest breakthroughs in cell
therapy, this is work that transforms the lives of patients, and
the careers of those who do it. You'll get the chance to grow and
thrive through opportunities uncommon in scale and scope, alongside
high-achieving teams rich in diversity. Take your career farther
than you thought possible.Bristol Myers Squibb recognizes the
importance of balance and flexibility in our work environment. We
offer a wide variety of competitive benefits, services and programs
that provide our employees with the resources to pursue their
goals, both at work and in their personal lives. Read more:
careers.bms.com/working-with-us .This Senior Director, Medical
Evidence Generation (MEG) Lead - Cell Therapy (CT) role in Global
Medical Affairs manages the evidence generation for the CT
portfolio (including Medical Affairs Sponsored studies [MAST] and
investigator-sponsored studies [ISR]) and provides leadership for
the cross-functional teams executing on the book of work. In this
role, he/she will have a key role ensuring the strategic data
generation needs for the CT organization are executed with speed
and rigor. This role requires bridging BMS to the best external
science through collaborations with academic institutions,
community networks of practicing clinicians, and professional
societies and associations. The CT MEG Team Lead will lead and
participate in cross-functional matrix leadership teams focused on
building these relationships and actively sourcing research
concepts that address critical evidence gaps for early and late
assets being developed in prioritized indications.This role will
report to the Vice President, Hematology and Cell Therapy, MEG TA
Lead and will be expected to:
- Drive the CT MEG book of work (including but not limited to
MASTs, ISRs and registries) ensuring they are on strategy and
executed with rigor and on time and in close collaboration with
GDO/WWM.
- Partner with the CT organization to develop the data generation
strategy, in partnership with prioritized external partners with
expertise in CT across Hematology, Immunology and Oncology.
- Provide medical/clinical accountability and oversight for the
various medical affairs-led sponsored studies (interventional and
non-interventional), in alignment with the Integrated Evidence
Plans (IEP) for the assets in company's portfolio.
- Collaborate with the TA Medical Lead, CTL, Clinical Scientist
(CS), and Global Trial Manager (GTM) for the development of the
Medical study protocol and ICF, authoring and providing medical
input during protocol development.
- Be accountable for medical data review of trial data, including
eligibility assessment and interpretation of trial data
results.
- Lead the team responsible for the co-development and
maintenance of the IEPs, in partnership with WWM teams, HEOR,
Development and other key internal stakeholders.
- Partner closely with key stakeholders across Medical, including
the Clinical Research Collaborations team, working on the cell
therapy portfolio to ensure cohesiveness and one MEG voice.
- Employ strong business acumen and fiscal stewardship focused on
driving reciprocal scientific value creation and allocate resources
consistent with company priorities.Qualifications & Experience
- Established strategic leadership experience serving at least
8-10 years in a pharmaceutical industry setting and possessing an
in-depth understanding of clinical and business development,
Medical Affairs, and Commercial functions related to the drug
development process.
- MD preferred, but not required, plus 2-3 years of clinical
trial experience, either in industry or academic setting; expertise
in drug development process and clinical research; experience with
implementation and conduction of medical affairs-led studies
desirable.
- Adeptness at building credibility with external investigators
and collaborative partners competently balancing business and
scientific acumen complemented by strong leadership behaviors,
authenticity, agility, and an enterprise mindset.
- Demonstrated ability to develop and sustain a high-performing
team along with a proven ability to successfully lead teams
(including matrix colleagues)
- Demonstrated track record of leadership in a complex, matrix
environment,
- Exceptional communication and interpersonal skills to influence
decision-making at all levels of the organization.This Position is
based at the Princeton Pike (PPK) site in Lawrenceville, NJ;
Expected travel -20%-30% within the US.#LI-HybridIf you come across
a role that intrigues you but doesn't perfectly line up with your
resume, we encourage you to apply anyway. You could be one step
away from work that will transform your life and career. Uniquely
Interesting Work, Life-changing CareersWith a single vision as
inspiring as Transforming patients' lives through science--- ,
every BMS employee plays an integral role in work that goes far
beyond ordinary. Each of us is empowered to apply our individual
talents and unique perspectives in an inclusive culture, promoting
diversity in clinical trials, while our shared values of passion,
innovation, urgency, accountability, inclusion and integrity bring
out the highest potential of each of our colleagues.On-site
Protocol BMS has a diverse occupancy structure that determines
where an employee is required to conduct their work. This structure
includes site-essential, site-by-design, field-based and
remote-by-design jobs. The occupancy type that you are assigned is
determined by the nature and responsibilities of your role:
Site-essential roles require 100% of shifts onsite at your assigned
facility. Site-by-design roles may be eligible for a hybrid work
model with at least 50% onsite at your assigned facility. For these
roles, onsite presence is considered an essential job function and
is critical to collaboration, innovation, productivity, and a
positive Company culture. For field-based and remote-by-design
roles the ability to physically travel to visit customers, patients
or business partners and to attend meetings on behalf of BMS as
directed is an essential job function. BMS is dedicated to ensuring
that people with disabilities can excel through a transparent
recruitment process, reasonable workplace
accommodations/adjustments and ongoing support in their roles.
Applicants can request a reasonable workplace
accommodation/adjustment prior to accepting a job offer. If you
require reasonable accommodations/adjustments in completing this
application, or in any part of the recruitment process, direct your
inquiries to adastaffingsupport@bms.com . Visit careers.bms.com/
eeo -accessibility to access our complete Equal Employment
Opportunity statement. BMS cares about your well-being and the
well-being of our staff, customers, patients, and communities. As a
result, the Company strongly recommends that all employees be fully
vaccinated for Covid-19 and keep up to date with Covid-19 boosters.
BMS will consider for employment qualified applicants with arrest
and conviction records, pursuant to applicable laws in your
area.Any data processed in connection with role applications will
be treated in accordance with applicable data privacy policies and
regulations.
Keywords: Disability Solutions, Trenton , Senior Director, Cell Therapy, Medical Evidence Generation (MEG) Lead, Healthcare , Princeton, New Jersey
Didn't find what you're looking for? Search again!
Loading more jobs...